The enzymes of the Antigen 85 complex (Ag85A, B, and C) possess mycolyltransferase activity and catalyze the synthesis of the most abundant glycolipid of the mycobacterial cell wall, the cord factor. The cord factor (trehalose 6,6'-dimycolate, TDM) is essential for the integrity of the mycobacterial cell wall and pathogenesis of the bacillus. Thus, TDM biosynthesis is regarded as a potential drug target for control of Mycobacterium tuberculosis infections. Trehalose 6,6'-dimycolate (TDM) is synthesized from two molecules of trehalose-6'-monomycolate (TMM) by antigen 85A. We report here a novel enzyme assay using the natural substrate TMM. The novel colorimetric assay is based on the quantification of glucose from the degradation of trehalose, which is the product from catalytic activity of antigen 85A.
. Due to the occurrence of Multi-Drug Resistant TB (MDR-TB) which is resistant to Rifampicin (Rif) and Isoniazid (INH), patients require a prolonged treatment with second-line drugs for up to 2 years, which increases the cost of treatment drastically. The epidemiological situation is deteriorating further due to the emergence of the so-called Extreme Drug Resistant (XDR) strains of MTB which are resistant not only to Rif and INH, but also to at least one of the second line TB drugs (White and Moore-Gillon, 2000) .
The cell wall is critical for long-term persistence of MTB in the hostile environment of the host's macrophage and for progression of tuberculosis (Barry et al., 1998; Brennan and Nikaido, 1995) . Mycobacteria are gram-positive bacilli, but the cell wall structures are different from those of other gram-positive bacteria (Brennan and Nikaido, 1995) .
Approximately one-half of the cell wall mass is comprised of mycolic acids. In the mycobacterium cell envelope, mycolic acids are esterified to the terminal pentaarabinofuranosyl unit of arabinogalactan, which is a peptidoglycan-linked polysaccharide (McNeil et al., 1991; Mikusova et al., 1995) . The inner layer of the cell wall is composed of mycolic acids covalently linked to the distal portion of the arabinogalactan (AG) moiety (Brennan and Nikaido, 1995; Liu and Nikaido, 1999) . The outer layer is composed of extractable glycolipids containing mycolic acids, such as trehalose 6'-monomycolate (TMM) and trehalose 6,6'-dimycolate (TDM), which accumulates in a cord-like fashion on the surface of the cells. Both mycolyl glycolipids TDM and TMM (the biosynthetic precursor of TDM), have been reported as powerful antigens (Fujita et al., 2006; Pan et al., 1999; Steingart et al., 2009; Wang et al., 1999) . The pathogenesis of tuberculosis is poorly understood, especially secondary and cavitary disease. There is evidence that suggests that cord factor (trehalose 6,6'-dimycolate, TDM) is a key driver of these processes. TDM is the most abundant lipid released by virulent MTB. TDM exists as cell wall bound and secreted forms. TDM bound to the mycobacterial cell wall is non-toxic and protects mycobacteria from killing by the host's macrophages (Hunter et al., 2006; Pan et al., 1999) . Secreted TDM accumulates with host lipids in alveoli, a process that rapidly produces caseation necrosis that leads to cavities. Virulent MTB release large amounts of TDM during growth as a pellicle within cavities. This process is thought to be crucial to perpetuate the cavity (Hunter et al., 2006) . The cord factor has been suggested to be an important determinant for successful infection and survival of MTB within macrophages (Indrigo et al., 2003) . Furthermore, it has been shown that 85A and 85B proteins are involved in the covalent attachment of mycolic acids to the mycobacterial cell wall (Puech et al., 2002) . Several studies strengthen the hypothesis that differential expression of the antigen 85 genes may be a mechanism utilized by mycobacteria to confuse and evade the host immune system (Armitige et al., 2000; Harth et al., 2002; Ronning et al., 2004) .
The cord factor (TDM) is synthesized by Antigen 85 (Ag85) complex proteins (Ag85A, Ag85B and Ag85C). The antigen 85 (Ag85) complex proteins are acyltransferases and convert TMM to TDM (Belisle et al., 1997) . Two molecules of TMM are bound to the substrate-binding pockets of the enzyme, and the mycolyl acyl group of the TMM substrate in the donor site is transferred to the TMM substrate bound in the acceptor site (Fig.1) . The reaction generates one molecule of TDM and one molecule of trehalose (Anderson et al., 2001; Toida et al., 1989) . Antigen 85 proteins are important for the survival of MTB in the host macrophage. An antigen 85C knockout strain of MTB has a 40% decrease in the amount of cell wall linked mycolic acid (Jackson et al., 1999; Sanki et al., 2008) . Furthermore, an fbpA -mutant is not able to grow in macrophage like cell-lines (Armitige et al., 2000) , Despite the knowledge concerning protein/substrate interactions and co-crystal structure of Antigen 85 (Klegerman et al., 1994; Ronning et al., 2004 ) the prerequisite for designing potent inhibitors to the mycolyltransferase activity is still the design of rapid and easy assays, suitable for HTS. Several synthetic analogues of trehalose and TMM, putative competitive inhibitors of their metabolism, have been shown to have dramatic effects on the glycolipid metabolism of mycobacteria. 6-azido-6-deoxy-α,α`-trehalose (ADT), completely suppresses the growth of M. aurum (Belisle et al., 1997; Hanessian and Lavallee, 1972) , and inhibits the in vitro mycolyltransferase activity of the purified recombinant antigen 85C about 60%. Finally, ADT reduces the synthesis of TMM (44 %) and TDM (87 %) (Belisle et al., 1997) .
Two mycolyltransferase assays have been reported, the first method is not suitable for HTS, due to the complexity and use of radioactive substances (Kremer et al., 2002; Sathyamoorthy and Takayama, 1987) . Another test published (Boucau et al., 2009) converted by trehalase to produce two molecules of glucose. Glucose is assayed by the glucose oxidase assay (Washko and Rice, 1961) . The amount of glucose is proportional to the trehalose concentration and so to the TMM concentration. A brief overview of the assay is depicted in Fig. 2 . We show that this simple spectrophotometric assay can be used for HTS for inhibitors targeting mycobacterium antigen 85 and for TMM quantification.
Materials and Methods

Bacterial culture
Mycobacterium smegmatis (mc 2 155) was grown in Middlebrook 7H9 medium supplemented with ADC enrichment (BD Diagnostic Systems, Sparks, MD). The cultivation was performed with shaking at 37 °C, and cells were harvested at their midlog phase of growth.
Extraction, isolation and purification of total lipids
Bacterial culture (0.5l) was centrifuged at 10.810g for 20 min. Lipids were extracted from the cell pellet with 20 volumes of chloroform/methanol (2:1, v/v) with stirring for overnight. The two phases were separated in a funnel. After the lower phase containing major glycolipid was collected, it was added to 500 ml of acetone at -20°C for 12 h. The solvent was evaporated off with a rotary evaporator. The total lipids were first separated by solvent fractionation and then by thin-layer chromatography (TLC) on silica plates (Macherey-Nagel, Germany) with the solvent system of chloroform/methanol/ammonium hydroxide (80:20:2, v/v) or with chloroform/methanol (9:1, v/v). For analytical purposes, glycolipid spots were visualized with a 9M H 2 SO 4 spray followed by charring at 110°C for 2 minutes or with Coomassie blue according to the method described previously with some modification (Nakamura and Handa, 1984) . Each developed TLC plate was air dried and immersed in a staining solution consisting paper by gentle pressing. For preparative purposes the spots were visualized by exposure to iodine vapour for a few minutes.
TMM purification
TMM was recovered from TLC plates after the iodine colour had disappeared by scratching out the spot from the plate and subsequent dissolving in chloroform/methanol (2:1, v/v).
TMM was purified until a single spot was obtained by repeating TLC (Fujita et al., 2005) . The yield was determined by weighing the dried product.
Plasmids and primers
The full-length of the M. tb H37Rv fbpA gene encoding the secreted form of antigen 85A lacking a stop codon was amplified by PCR. The sequence of PCR sense primer for Rv3804c gene was 5`-ggc tgt cat atg gca ttt tcc cgg ccg ggc tt -3` and that of anti-sense primer was 5`-ggt acc gga tcc cta ggc gcc ctg ggg cgc gg -3`. The PCR product was digested with FastDigest clarified by centrifugation (10,866g) for 20 min. The antigen 85A was purified by affinity chromatography using a Ni-NTA column on a ÄKTA purifier system (GE-Healthcare).
Antigen 85A was purified by applying a linear imidazole gradient from 10 -500 mM. The fractions containing antigen 85A were pooled, the enzyme was detected by using SDS/PAGE and western blotting. The final purification step used size exclusion chromatography on a Superdex 200 prep-grade column (XK 26/60, Amersham Biosciences). The fractions containing antigen 85A were pooled and stored at 4°C.
Protein analysis
The purity of purified proteins was assessed by SDS/PAGE on 12% (w/v) polyacrylamide gels stained with Coomassie Brilliant Blue R-250. Molecular mass marker proteins were from
Fermentas. The immune blotting was conducted by using a semi-dry blotting device (Sigma).
The fractions were electrophoresed through preparative 12% (w/v) polyacrylamide gels and were transferred to polyvinylidene fluoride (PVDF) membranes (Millipore), then the membranes were placed in a blocking solution consisting of 1X PBS plus 0.5% Tween 20
(PBST) and 2% (w/v) bovine serum albumin (Sigma). After blocking for 2 hour, the membrane was incubated with mouse anti 85A mAb IgG (Lionex, Germany) for overnight with gentle rocking. Then the membrane was washed three times with PBST and was incubated with horseradish peroxidase-conjugated anti-mouse IgG (goat origin; Pierce Chemical Co.) diluted 1:10,000 in PBST for 30 minutes. Blots were again washed three times with PBST and finally developed in membrane peroxidase substrate (Seramun Diagnostica).
Determination of enzyme concentration
The enzyme concentration was determined by absorbance spectroscopy with 280 nm wavelength light. Additionally, absorbance at 260 nm was measured to calculate the A 280nm /A 260nm ratio. The readings were performed on a geneQuant spectrophotometer (Pharmacia). website (Wilkins et al., 1999) . The predicted extinction coefficient for the recombinant antigen 85A protein was 73.005 M -1 cm -1 .
Mycolyltransferase assay
The 
Analysis of kinetic parameters
To determine K m and K cat , the following setup was used: TMM concentrations ranging from The enzyme obeyed the Michaelis-Menten equation. The kinetic data were calculated and plotted by using GraphPad Prism 5.02 (GraphPad Software, Inc.).
Results and Discussion
Isolation and purification of TMM
Mycobacterium smegmatis cells were harvested at the midlog phase of growth. The total lipids were extracted and applied to a silica gel TLC plate, followed by development in chloroform/methanol/ammonium hydroxide (80:20:2, by vol.) or chloroform/methanol (9:1, by vol.). Both mixtures achieved a fairly good resolution of the mycolate-containing glycolipids TMM and TDM. The chloroform/methanol (9:1 by vol.) allowed a wider inclination (Fig. S1B) . Using chloroform/methanol/ammonium hydroxide as mobile phase TMM and TDM had an R f of 0.16 and 0.36. The R f ratio obtained were 0.26 and 0.68, respectively with chloroform/methanol.
Purification of antigen 85A
After the two-step purification (Ni-NTA and size exclusion chromatography), antigen 85A (Fig. S2 ). An additional absorbance reading at 260 nm allowed the calculation of the A 280nm /A 260nm ratio to confirm that the A280 nm value represents the true protein concentration and not the concentration of a protein/nucleic acid mixture. The A 280nm /A 260nm ratio for purified antigen 85A used in the assay was 1.9, indicating that little or no nucleic acid was present in the sample because nucleic acid contamination decrease the ratio from approximately 2.0 to 1.57-1.28.
Assay design and substrate specificity
The basic idea for this assay was the need for a fast and stable assay for the analysis of kinetic parameters of antigen 85A and secondly, a method for the quantification of glycolipids in cell extracts. Known assays use synthetic substrates or radioactive labelled substrates. Boucau et al.(2009) describe for example an assay using the artificial substrate p-nitrophenyl-6-Ooctanoyl-β-D-glucopyranoside. Since this substrate, is different form the natural substrate we invented an assay using the natural substrate TMM, which can be easily isolated from several organisms (Fujita, et al., 2005) and reflects best the kinetic parameters of the enzyme. Antigen 85A produces one molecule of trehalose per reaction cycle. We used trehalase to convert trehalose to glucose, which can be easily measured. Trehalase hydrolyzes the O-glycosyl bond of trehalose to yield two molecules of glucose. Quantification of glucose is finally achieved by a commercial glucose quantification assay. A prerequisite for the assay was the observation that trehalase from porcine kidney neither uses TMM nor TDM as substrate because if these compounds will react in the assay may give a false-positive result (Data not shown).
Optimal enzyme concentration, general setup and linearity
The assay was designed first for the kinetic characterization of antigen 85A. As substrate, freshly isolated TMM was used. TMM was dissolved in Tris buffer with DTT using ultrasonication. These assays were done with ultrasonicated TMM. TMM was weighted from dried material obtained by TLC as described in the Materials and Methods section. In this assay, glucose concentration increases with respect to time with a fixed amount of substrate used. As shown in Fig. 3 and Fig. 4B , TMM is completely converted to glucose within 30 minutes. In order to ensure that the assay was functioning as expected and that each step of the assay was dependent on the presence of all components, control reactions were carried out in the presence and absence of both enzymes antigen 85A and trehalase (Fig. 3) .
Without any enzyme present there is no increase in absorbance observed over time, showing that the chromophore is not released by non-enzymatic hydrolysis under our conditions. The addition of trehalase caused a slight increase in absorbance over time. Addition of antigen 85A to the reaction mixture produced a significant increase of absorbance and glucose concentrations over time. To further validate the method, the dependence of the reaction rate on the antigen 85A and TMM concentrations was studied. Fig. 4B shows the plot corresponding to different antigen 85A concentrations (125, 150, 175, 200, 225, and 250 nM) .
The data illustrate the increasing rate of glucose production with increasing concentration of antigen 85A. Fig. 4A shows the linearity observed between glucose and TMM concentration.
TMM determination from organic solvents
For the purpose of TMM quantification from total lipids extraction steps, the assay was respectively. In spite of it, the antigen 85A can be assayed in processes where methanol and mixture of chloroform/methanol are used.
Enzymatic characterization of antigen 85A
With TMM as substrate, the enzyme had an apparent K m of 129.6 ± 8.1 µM, a V max of 11.4 ± 0.7 µM min -1 and K cat of 65.4 ± 4.1 min -1 . These values are quite similar to those reported for the (Ag85 fold family) α/β hydrolase superfamily of enzymes like acetylcholinesterase (AChEs), polyketide synthase thioesterase (PKS-TE) from Bacillus brevis and Mycobacterium tuberculosis Rv3802c (Parker et al., 2009; Rosenberry and Bernhard, 1971; Trauger et al., 2000) . Kinetic studies of antigen 85C reveal the K m and K cat values to be 47 ± 8 µM and 0.062 s -1 respectfully (Boucau et al., 2009 ). The lower K cat value of 0.062 s -1 of the antigen 85C may result from the artificial substrate used.
Validation
The Z′ factor is a measurement of the quality and power of a HTS assay and was developed for the evaluation of the inherent signal-to-noise ratio and to assess the assay reproducibility (Zhang et al., 1999) . In order to calculate this factor and to assess the robustness of the assay protocol in microplate format, a series of negative and positive controls in different volumes were used. For the negative control assay, reactions were performed in the presence of trehalase without antigen 85A. Using the same assay conditions mentioned previously, the positive control assay was performed. Based on the data, the Z′ value was calculated to be 0.67-0.73 (Table S1) This was confirmed by performing a number of assays (data not shown).
In conclusion, this article has described a new and low-cost colorimetric method based on the reaction with TMM as natural substrate, which brings flexibility and convenience in screening of antigen 85A inhibitors. This assay is significantly faster and more convenient to use than those described to date (Boucau et al., 2009; Kremer et al., 2002; Sathyamoorthy and Takayama, 1987) , and enables the measurement of amounts of TMM, one of the most important lipids in MTB cell wall. We are currently using this method for TDM and TMM quantification in different strains and mutants to better understand the reactions that control the biosynthesis of the glycolipids and for the screening of drug libraries. Reaction scheme for novel mycolyltransferase activity assay. Using trehalose that is produced as one of final products of mycolyltransferase reaction by trehalase to produce glucose, which is oxidized to gluconic acid and hydrogen peroxidase by glucose oxidase.
Hydrogen peroxide reacts with o-dianisidine in the presence of peroxidase to produce a colored product (oxidized o-dianisidine), which will be converted to a stable colored product by sulfuric acid. The colored product is measured at 540 nm. The calculated K m is 129.6 ± 8.1 µM and V max is 11.4 ± 0.7 µM min.
